Skip to main content
. 2022 Feb 2;388(2):417–438. doi: 10.1007/s00441-022-03593-1

Fig. 1.

Fig. 1

Experimental design. ALO: alogliptin; CMC: carboxymethylcellulose; CP: cyclophosphamide; i.p.: intraperitoneal; p.o.: per oral